Prof. Dr. med. Peter Fasching



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Personal Profiling im Bereich der Senologie (2025) Behrens A, Beckmann M, Fasching P, Hübner H, Emons J Journal article AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2025 (2025) Thill M, Janni W, Albert US, Banys-Paluchowski M, Bartsch R, Bauerfeind I, Bjelic-Radisic V, et al. Journal article, Review article AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2025 (2025) Park-Simon TW, Müller V, Albert US, Banys-Paluchowski M, Bartsch R, Bauerfeind I, Bjelic-Radisic V, et al. Journal article, Review article Therapy of early breast cancer: current status and perspectives (2025) Tauber N, Amann N, Dannehl D, Deutsch TM, Dimpfl M, Fasching P, Hartkopf A, et al. Journal article, Review article COGNITION-GUIDE - Genomics-Guided Targeted Post-Neoadjuvant Therapy in Patients with Early Breast Cancer: Study Design of a Multicenter, Open-Label, Umbrella Phase II Study (2025) Pixberg C, Maurer C, Smetanay K, Straβl L, Hlevnjak M, Zapatka M, Wagner CV, et al. Journal article Indirect Treatment Comparison between Ribociclib Combined with Non-Steroidal Aromatase Inhibitors and Ovarian Function Suppression vs. Tamoxifen in Premenopausal Women with Early Breast Cancer (2025) Lüftner D, Banys-Paluchowski M, Hartkopf AD, Hörner M, Janni W, Langanke D, Müller V, et al. Journal article Correction to: Comparative assessment of breast volume using a smartphone device versus MRI (Breast Cancer, (2025), 32, 1, (166-176), 10.1007/s12282-024-01647-6) (2025) Behrens A, Hübner H, Häberle L, Stamminger M, Zint D, Heindl F, Emons J, et al. Journal article, Erratum Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers. (2025) Häberle L, Erber R, Gaß P, Hein A, Niklos M, Volz B, Hack C, et al. Journal article Style-Extracting Diffusion Models for Semi-supervised Histopathology Segmentation (2025) Öttl M, Wilm F, Steenpaß J, Qiu J, Rübner M, Hartmann A, Beckmann M, et al. Conference contribution, Original article A Digital Home-Based Health Care Center for Remote Monitoring of Side Effects During Breast Cancer Therapy: Prospective, Single-Arm, Monocentric Feasibility Study (2025) Hübner H, Wurmthaler L, Goossens C, Ernst M, Mocker A, Krückel A, Kallert M, et al. Journal article